Lipella Pharmaceuticals I...

NASDAQ: LIPO · Real-Time Price · USD
0.64
0.00 (0.05%)
At close: Aug 15, 2025, 2:41 PM
0.64
0.00%
After-hours: Aug 15, 2025, 02:41 PM EDT

Lipella Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Mar 31, 2021
Cash & Equivalents
4.23M 2.18M 1.35M 1.19M 2.11M 3.29M 2.41M 3.11M 4.02M 5.12M 114.77K 434.98K 414.4K 1.41M -606.74K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 600.54K 300.55K 1.21M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a -122.55K n/a -150.82K -164.63K -178.23K n/a n/a -606.74K
Receivables
85.63K 84.71K 31.08K 35.33K 68.93K 32.29K 53.14K 28.04K 83.97K 113.66K n/a n/a n/a n/a n/a
Inventory
n/a n/a -31.08K n/a n/a n/a -261.01M -253.12M n/a -113.66K n/a n/a n/a n/a n/a
Other Current Assets
-1 n/a 31.08K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
4.82M 2.62M 2.08M 2.08M 3.01M 3.43M 2.67M 3.37M 4.48M 5.8M 709.15K 872.53K 1.33M 1.81M 606.74K
Property-Plant & Equipment
32.71K 56.62K 80.14K 103.28K 126.07K 147.89K 169.88K 122.55K 136.79K 150.82K 164.63K 178.23K 187.22K 204.8K n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
32.71K 56.62K 80.14K 103.28K 126.07K 147.89K 169.88K 122.55K 136.79K 150.82K 164.63K 178.23K 187.22K 204.8K -606.74K
Total Assets
4.86M 2.67M 2.16M 2.18M 3.14M 3.58M 2.84M 3.49M 4.61M 5.95M 873.78K 1.05M 1.52M 2.01M n/a
Account Payables
392.12K 388.19K 459.45K 178.36K 293.83K 138.02K 303.05K 22.06K 148.92K 384.36K 352.36K 55.48K 56.46K 46.9K n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a -158.25M -215.74M n/a n/a n/a n/a n/a 178.97K n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a 250K 275K 25K 25K 25K 25K n/a
Other Current Liabilities
-1 237.89K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -357.93K n/a
Total Current Liabilities
776.85K 754.42K 701.19K 480.31K 551.88K 385.36K 548.73K 298.8K 717.45K 1.18M 741.65K 447.69K 346.31K 340.63K n/a
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 50K 50K 50K 50K n/a
Other Long-Term Liabilities
1.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a 33.62K 32.52K 31.43K 30.35K n/a
Total Long-Term Liabilities
1.00 n/a n/a 1.00 24K 47.37K 70.48K 65.39K 80.94K 96.26K 194.96K 250.88K 249.79K 248.71K n/a
Total Liabilities
776.85K 754.42K 701.19K 480.31K 575.88K 432.73K 619.21K 364.19K 798.39K 1.27M 936.61K 698.57K 596.1K 589.34K n/a
Total Debt
24K 47.6K 70.83K 93.68K 115.7K 136.59K 157.76K 126.18K 390.46K 429.52K 243.36K 256.99K 265.78K 282.96K n/a
Common Stock
254.00 121.00 109.00 761.00 704.00 605.00 580.00 574.00 574.00 574.00 1.05K 967.00 967.00 967.00 n/a
Retained Earnings
-16.65M -15.34M -13.9M -12.45M -11.52M -10.32M -9.63M -8.31M -6.77M -5.7M -5.34M -4.63M -3.85M -3.11M n/a
Comprehensive Income
n/a n/a n/a n/a n/a n/a 0.00 n/a n/a n/a 0.00 n/a -3.85M -3.11M 463.16K
Shareholders Equity
4.08M 1.92M 1.46M 1.7M 2.56M 3.14M 2.22M 3.13M 3.82M 4.68M -62.82K 352.19K 920.75K 1.42M 463.32K
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 600.54K 300.55K 1.21M